Navigation Links
Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care

ORANGE COUNTY, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), announced today that it has signed new sole source agreements with Adventist Health to provide a broad range of core laboratory systems and supplies valued at approximately $36 million over six years. Adventist Health is a not-for-profit, faith-based health care system with facilities in California, Hawaii, Oregon, and Washington.


Under the terms of the new six-year agreements, Adventist Health hospital laboratories will continue to purchase hematology products from Beckman Coulter, and will add the company's complete line of automated chemistry and immunoassay analyzers and reagents to their owned, leased and managed facilities. An expanding group of more than 38 acute-care affiliate organizations will also be able to purchase systems under the contract.

In making the decision, Adventist Health cited Beckman Coulter's ability to deliver cutting-edge technologies that can help their physicians deliver prompt and effective patient care. Lowell Church, assistant vice president, said, "We are constantly striving to enhance quality care, increase patient safety and improve outcomes, in addition to controlling costs. Beckman Coulter has the same vision and goals and we look forward to collaborating with them."

David Bespalko, corporate vice president of sales in North America for Beckman Coulter, said about the contract, "These agreements are a great opportunity to continue to demonstrate our commitment to improving patient health and reducing the cost of care. Our innovative systems simplify and automate laboratory processes, helping to improve the efficiency of our laboratory partners."

About Adventist Health.

Adventist Health is a faith-based, not-for-profit health care system with headquarters in Roseville, California and more than 18,000 employees. The system has operations in California, Hawaii, Oregon, and Washington, including 18 acute care facilities; numerous clinics and outpatient facilities, including the largest network of rural health clinics in California; 15 home care agencies; and three joint-venture retirement centers. To learn more, visit

About Beckman Coulter, Inc.

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents approximately 78 percent of the company's 2007 annual revenue of $2.76 billion. For more information, visit

Contacts: Mary Luthy, Beckman Coulter Allan Harris, Beckman Coulter

Corporate Communications Investor Relations

(714) 773-7964 (714) 773-7620

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Beckman Coulter to Present at the Oppenheimer Annual Healthcare Conference
2. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
3. Beckman Coulter Investor Events Second Half of 2008
4. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
5. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
6. Beckman Coulter Announces Second Quarter 2008 Results
7. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
8. Upcoming Beckman Coulter Investor Events Second Half of 2008
9. Beckman Coulter to Present at Upcoming Healthcare Conferences
10. Beckman Coulter Announces First Quarter 2008 Results
11. Beckman Coulter Acquires Rights to Hepatitis C Virus
Post Your Comments:
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... today that it has closed the sale of its ... Guerbet (GBT- NYSE Euronext) in a transaction valued at ... manufacturing facilities and a total of approximately 1,000 employees ... St. Louis area. This entire ...
(Date:11/26/2015)... England , November 26, 2015 ... medical device company specializing in imaging technologies, announced today that ... Commission as part of the Horizon 2020 European Union Framework ... out a large-scale clinical trial in breast cancer. ... , --> --> ...
(Date:11/25/2015)... 25, 2015 Studies reveal the ... plaque and pave the way for more effective treatment for ...     --> --> ... health problems in cats, yet relatively little was understood about ... studies have been conducted by researchers from the WALTHAM Centre ...
(Date:11/25/2015)... ... 25, 2015 , ... A long-standing partnership between the Academy ... been formalized with the signing of a Memorandum of Understanding. , AMA Executive ... Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA Headquarters ...
Breaking Biology Technology:
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... RESTON, Va. , Oct. 29, 2015 ... announced today that it has released a new version ... Daon customers in North America ... gains. IdentityX v4.0 also includes a FIDO UAF ... customers are already preparing to activate FIDO features. These ...
(Date:10/29/2015)... 29, 2015 NXTD ) ... focused on the growing mobile commerce market and ... StackCommerce, a leading marketplace to discover and buy ... smart wallet on StackSocial for this holiday season. ... the "Company"), a biometric authentication company focused on ...
Breaking Biology News(10 mins):